The 2024 Citeline Awards have recognized UBC as a finalist in the category of Excellence in Use of Real-World Data/Evidence. This is now the third year in a row that UBC has been named a finalist for these awards.
The study UBC is recognized for includes tokenizing the data of pragmatic trial participants and linkages to 16 real-world data sources. The goal is to inform understanding of the patient journey before and after enrollment, as well as assess medication effectiveness and safety risks against usual care.
As a leader in modernized study designs that generate critical real-world evidence of safety and effectiveness, UBC is proud to be recognized for our work on this study design and execution. If you would like to learn more about how UBC incorporates the right mix of tools and techniques to efficiently and effectively achieve your study aims, get in touch with us here.
